Fosun Pharma and Shenzhen Government Collaborate on $700M Healthcare Fund for Biomedicine Innovation
Thursday, 14 March 2024, 11:00
Fosun Pharma and Shenzhen Government Form Partnership
Fosun Pharma has teamed up with the Shenzhen government to raise a 5-billion yuan (US$700 million) healthcare fund to invest in start-ups and innovations in cellular biology, genetics, and other fields related to biomedicine.
Key Points:
- Collaboration: Fosun Pharma and Shenzhen's government join forces to support biomedicine innovation.
- Focus Areas: The fund aims to invest in startups working in cellular biology and genetics.
- Strategic Investment: The partnership signifies a significant commitment to fostering innovation in the biomedicine sector.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.